Cellular localization of AT1 receptor mRNA and protein in normal placenta and its reduced expression in intrauterine growth restriction. Angiotensin II stimulates the release of vasorelaxants.
about
Pathophysiology of placentation abnormalities in pregnancy-induced hypertensionIntracellular Angiotensin II and cell growth of vascular smooth muscle cellsAssociation of dysfunctional synapse defective 1 (SYDE1) with restricted fetal growth - SYDE1 regulates placental cell migration and invasionEarly streptozotocin-diabetes mellitus downregulates rat kidney AT2 receptors.The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsia.Tissue transglutaminase contributes to the pathogenesis of preeclampsia and stabilizes placental angiotensin receptor type 1 by ubiquitination-preventing isopeptide modification.Vasoreactivity of chorionic plate arteries in response to vasoconstrictors produced by preeclamptic placentas.Contractile effects by intracellular angiotensin II via receptors with a distinct pharmacological profile in rat aorta.Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling.Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy.Maternal protein restriction reduces expression of angiotensin I-converting enzyme 2 in rat placental labyrinth zone in late pregnancy.Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling.Angiotensin II regulation of ovine fetoplacental artery endothelial functions: interactions with nitric oxide.Expression of the renin-angiotensin system in a human placental cell line.AT1, AT2, and AT(1-7) receptor expression in the uteroplacental unit of normotensive and hypertensive rats during early and late pregnancy.Contractility of placental vascular smooth muscle cells in response to stimuli produced by the placenta: roles of ACE vs. non-ACE and AT1 vs. AT2 in placental vessel cells.The functional role of the renin-angiotensin system in pregnancy and preeclampsia.Systemic and uteroplacental renin--angiotensin system in normal and pre-eclamptic pregnancies.Local Renin-Angiotensin system in the reproductive system.Activation of local chorionic villi angiotensin II levels but not angiotensin (1-7) in preeclampsia.Glioblastoma Multiforme Cancer Stem Cells Express Components of the Renin-Angiotensin SystemAetiology and physiopathology of preeclampsia and related forms.Is there a role of the local tissue RAS in the regulation of physiologic and pathophysiologic conditions in the reproductive tract?A complicated role for the renin-angiotensin system during pregnancy: highlighting the importance of drug discovery.Inflammation, Autoimmunity, and Hypertension: The Essential Role of Tissue Transglutaminase.Transforming growth factor beta1 regulates angiotensin II type I receptor gene expression in the extravillous trophoblast cell line SGHPL-4.Expression of placental leucine aminopeptidase and adipocyte-derived leucine aminopeptidase in human normal and malignant invasive trophoblastic cells.The functional regeneration of syncytiotrophoblast in cultured explants of term placenta.High-sodium intake prevents pregnancy-induced decrease of blood pressure in the rat.Modulation of body fluids and angiotensin II receptors in a rat model of intra-uterine growth restriction.Role of p53-dependent placental apoptosis in the reproductive and developmental toxicities of caffeine in rodents.Angiotensin II receptor (type 1 and 2) expression peaks when placental growth is maximal in sheep.Uteroplacental restriction in the rat impairs fetal growth in association with alterations in placental growth factors including PTHrP.
P2860
Q24649934-27D3C6D9-DF44-462C-9AD6-B4929A82821CQ28361248-3262A6AD-A9F6-4C66-8749-4EF87239E476Q29147510-10506DE9-2118-4E6E-85EE-32EF8B89AB32Q32032127-430619EF-2939-49E6-BEBB-F796D036B969Q33591058-BBF73F61-ECDE-404A-9BB1-556570F6866AQ33737470-ACD1C4FE-E152-4D63-B8E2-705E20511D27Q34577349-6BFCD072-9AA9-4226-AD58-72B9BB95D693Q35028572-0ECB63CC-3171-4EB0-9EB7-4501F0A5C2FEQ35681804-43563152-4790-40B9-8255-EF9F2F63D2BBQ35699115-C6107C44-0D99-4694-A1DF-3F7240D2D3F9Q35790978-DF479E3B-A6D1-44F1-9EFE-63859300C4F4Q36050771-F9DB8064-70E5-4F0E-A9E1-FB0618A45195Q36080082-86C4900A-5B5B-4159-9FCF-3CD20DB9B25CQ36611683-2F36E0B5-4615-48D6-892F-D404F3DFFADCQ36824901-2F81DB84-585F-4A48-BD08-D1F80983198EQ36915124-DFCFF89D-E82E-48EB-A71E-C427E83CEEDDQ37039872-C3FD8C55-D582-4C0D-8E91-822AE10DAF59Q37218199-FEED32B6-CEE9-4D5B-A176-BA157D44D7F6Q37235107-5D6CDB32-077A-4074-BC44-9009E477816BQ37250421-1BB604C2-7C6D-4C1E-B5E5-5895F9DA077AQ37284738-F2CCC248-6BD6-4933-BAEB-A57D3524E397Q37800883-EBE0E304-D05B-4F42-BAEC-1B0FA998A13FQ37913719-0D06D7C6-1B3F-4120-A927-C52149886588Q38126570-EC6417FA-7AD8-4A9D-AA41-90908C3CC45CQ39198610-3B83AE3E-C3C8-42AC-9213-9579408FDC9BQ40341527-39C44C4A-F0B7-4FF5-A2A3-4F6196B92AABQ40604750-C773DD37-D878-40F6-AE68-B2D8EB2BE080Q42501082-90F130B5-7F2C-4383-B933-5419B06A6148Q44470075-F11FD5B8-DB09-4332-B3D4-D6A737A93A97Q45147849-6D5791BF-40BF-4245-8957-E768D8ACBE8FQ51368427-C8322F2D-8530-48F5-A04E-3D92A43CF8F2Q54076543-96F57962-2B45-4737-ABB7-4FFD1513F385Q54684339-A404746D-7E86-42D3-9C4A-8F47AC9C6602
P2860
Cellular localization of AT1 receptor mRNA and protein in normal placenta and its reduced expression in intrauterine growth restriction. Angiotensin II stimulates the release of vasorelaxants.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1998
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cellular localization of AT1 r ...... the release of vasorelaxants.
@en
Cellular localization of AT1 r ...... the release of vasorelaxants.
@nl
type
label
Cellular localization of AT1 r ...... the release of vasorelaxants.
@en
Cellular localization of AT1 r ...... the release of vasorelaxants.
@nl
prefLabel
Cellular localization of AT1 r ...... the release of vasorelaxants.
@en
Cellular localization of AT1 r ...... the release of vasorelaxants.
@nl
P2093
P2860
P356
P1476
Cellular localization of AT1 r ...... the release of vasorelaxants.
@en
P2093
P2860
P304
P356
10.1172/JCI119881
P407
P577
1998-01-01T00:00:00Z